CN Stock MarketDetailed Quotes

Sichuan Kelun Pharmaceutical (002422)

Watchlist
  • 34.57
  • +0.47+1.38%
Market Closed Apr 30 15:00 CST
54.99BMarket Cap34.99P/E (TTM)

Sichuan Kelun Pharmaceutical (002422) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Non infusion8.87B47.90%
Infusion7.48B40.43%
Research and development projects1.51B8.17%
Other business648.53M3.50%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing16.35B88.32%
Research and development projects1.51B8.17%
Other business648.53M3.50%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China5.01B27.08%
Southwest3.7B19.98%
International business2.49B13.44%
Central China2.22B12.00%
North China1.69B9.12%
South China1.43B7.73%
Northwest742.01M4.01%
Other business648.53M3.50%
Northeast China580.96M3.14%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More